FRAGis formulated with aspecific active fragment of Thymosin Beta 4, supplied in microgram amounts and delivered in a delayed-release vegetable capsule.

The formulation uses a focused peptide profile designed for individuals seeking aThymosin Beta 4 peptide supplementwith clearly disclosed ingredient sourcing and minimal excipients. FRAG is not an injectable product and does not contain pharmaceutical or prescription ingredients.

Select formulations may includeD-ribose or natural thymus extract, depending on the version.